BR100 Increased By (0.75%)
BR30 Increased By (0.97%)
KSE100 Increased By (0.44%)
KSE30 Increased By (0.44%)
BECO 6.19 Increased By ▲ 0.42 (7.28%)
BML 52.82 Decreased By ▼ -0.18 (-0.34%)
BOP 34.32 Increased By ▲ 0.33 (0.97%)
CNERGY 8.15 Increased By ▲ 0.04 (0.49%)
DCL 12.30 Increased By ▲ 0.10 (0.82%)
FCCL 53.40 Increased By ▲ 0.57 (1.08%)
FCSC 5.20 Increased By ▲ 0.13 (2.56%)
FFL 18.10 Increased By ▲ 0.15 (0.84%)
FNEL 1.31 Increased By ▲ 0.02 (1.55%)
HUMNL 10.85 Decreased By ▼ -0.03 (-0.28%)
KEL 8.09 Increased By ▲ 0.07 (0.87%)
KOSM 5.26 Decreased By ▼ -0.26 (-4.71%)
MLCF 87.30 Increased By ▲ 0.79 (0.91%)
NBP 186.99 Increased By ▲ 1.83 (0.99%)
PACE 10.68 Increased By ▲ 0.10 (0.95%)
PAEL 39.76 Increased By ▲ 0.34 (0.86%)
PIAHCLA 26.11 Decreased By ▼ -0.11 (-0.42%)
PIBTL 16.98 Increased By ▲ 0.31 (1.86%)
PPL 229.36 Increased By ▲ 1.18 (0.52%)
PRL 34.94 Increased By ▲ 0.26 (0.75%)
PTC 66.75 Increased By ▲ 1.42 (2.17%)
SEARL 90.61 Increased By ▲ 0.48 (0.53%)
SSGC 26.86 Increased By ▲ 0.26 (0.98%)
TELE 8.63 Increased By ▲ 0.35 (4.23%)
THCCL 58.71 Increased By ▲ 0.21 (0.36%)
TPLP 8.63 Increased By ▲ 0.41 (4.99%)
TREET 24.80 Increased By ▲ 0.27 (1.1%)
TRG 69.74 Increased By ▲ 0.03 (0.04%)
WAVES 10.01 Increased By ▲ 0.07 (0.7%)
WTL 1.29 Increased By ▲ 0.01 (0.78%)
By

LONDON: European equities fell in opening deals on Tuesday after the head of Moderna warned current coronavirus vaccines might be less effective at fending off the Omicron variant.

In initial trade, London’s benchmark FTSE 100 index reversed 0.9 percent to 7,047.14 points.

In the eurozone, Frankfurt’s DAX shed 0.9 percent to 15,137.86 points and the Paris CAC 40 lost 1.1 percent to 6,702.83.

Asian bourses and oil prices also took a tumble following the remarks.

Moderna chief executive Stephane Bancel’s comments, in an interview with the Financial Times, sent traders running for cover.

“There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,” he told the daily business newspaper.

The high amount of mutations on Omicron and its swift spread in South Africa indicated the present jabs would need to be tweaked, he indicated.

“Bancel ... predicted existing vaccines would struggle with the Omicron variant,” said CMC Markets analyst Michael Hewson.

The Moderna chief “warned it would take months for pharmaceutical companies to manufacture enough jabs at a sufficient scale to make a difference”, Hewson added.

“His tone contrasts with the likes of Pfizer and BioNTech was suggested any new vaccine would be able to modified fairly quickly.”

Comments

Comments are closed for this article.